B3GAT2: A Potential Drug Target for Neurological Disorders (G135152)

Target Name: B3GAT2

NCBI ID: G135152

B3GAT2: A Potential Drug Target for Neurological Disorders

B3GAT2 (B3GA2_HUMAN) is a protein that is expressed in human tissues and has been identified as a potential drug target or biomarker. The protein is a key component of the nervous system and is involved in the development and maintenance of neuronal connections.

Research has shown that B3GAT2 plays a role in the regulation of synaptic plasticity, which is the ability of the nervous system to change and adapt in response to experience. B3GAT2 has been shown to promote the formation of new neurons and to modulate the activity of existing neurons.

Additionally, B3GAT2 has been shown to be involved in the regulation of neurotransmitter release and the modulation of pain perception. This suggests that it may be a useful target for the development of new treatments for a variety of neurological and psychiatric disorders.

Despite the potential benefits of B3GAT2 as a drug target, further research is needed to fully understand its role in the nervous system and its potential as a therapeutic agent.

In conclusion, B3GAT2 is a protein that has the potential to be a drug target or biomarker for a variety of neurological and psychiatric disorders. Further research is needed to fully understand its role in the nervous system and its potential as a therapeutic agent.

Protein Name: Beta-1,3-glucuronyltransferase 2

Functions: Involved in the biosynthesis of L2/HNK-1 carbohydrate epitope on both glycolipids and glycoproteins

More Common Targets